To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Complication Rates of BMAC vs Other Injectables for Knee Osteoarthritis

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
August 2025

Complication Rates of BMAC vs Other Injectables for Knee Osteoarthritis

Vol: 307| Issue: 8| Number:53| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Complication rates of bone marrow aspirate concentrate injections versus other injectable therapies for knee osteoarthritis: A systematic review and meta-analysis.

J Orthop. 2025 01-Apr;():. 10.1016/j.jor.2024.10.005

Contributing Authors:
S Fucaloro JT Bragg MW Feldman L Krivicich MJ Salzler

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Six randomized controlled trials including 860 patients with knee osteoarthritis were included in this systematic review and meta-analysis comparing bone marrow aspirate concentrate (BMAC) injections versus other injectable therapies. Pooled outcomes of interest included overall complication rates, early (≤7 days) complications, late (>7 days) complications, type of complication (pain, effusion, i...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue